Sentences with phrase «autologous stem cell transplant»

«Meta - regression analyses failed to demonstrate any association between CR or (CR or VGPR) with either overall survival or progression - free survival both in patients receiving autologous stem cell transplant [ASCT] and in non-ASCT patients.»

«Lenalidomide maintenance following autologous stem cell transplant can now be considered a standard of care for people with multiple myeloma,» says Dr. McCarthy, senior author on the meta - analysis and Principal Investigator of the U.S. study, CALGB (Alliance) 100104.

The therapy is approved by the U.S. Food and Drug Administration for relapsed or treatment - resistant Hodgkin lymphoma, and it is commonly prescribed to patients whose disease has progressed after autologous stem cell transplant, a procedure that replenishes the bone marrow with the patient's own healthy stem cells after therapy.

Results from a clinical trial investigating a new T cell receptor (TCR) therapy that uses a person's own immune system to recognize and destroy cancer cells demonstrated a clinical response in 80 percent of multiple myeloma patients with advanced disease after undergoing autologous stem cell transplants (ASCT).

Prior to receiving the therapy, the patient had already received nine different therapy regimens in the five years since her diagnosis, including a previous autologous stem cell transplant, which had only controlled her disease for a few months.

Notable among these are the use of BV prior to autologous stem cell transplant in Hodgkin lymphoma patients, to treat additional CD30 - positive lymphomas, and in patients with relapsed or treatment - resistant non-Hodgkin lymphoma.

This is the «show reel» of Dr Haluk Deda, a Turkish neurosurgeon who is setting up shop in Dubai, where he plans to offer autologous stem cell transplants to treat chronic spinal cord injuries and ALS, a condition with no known cure that generally leads to death within three to five years of diagnosis.

According to researchers, people with HIV - associated lymphoma who receive autologous stem cell transplant have similar survival rates and are no more at risk of serious complications compared to those without HIV receiving this therapy.

The study, «Lenalidomide (LEN) maintenance (MNTC) after high - dose melphalan and autologous stem cell transplant (ASCT) in multiple myeloma (MM): A meta - analysis (MA) of overall survival (OS),» is ASCO 2016 abstract no. 8001 and will be discussed during the Hematologic Malignancies — Plasma Cell Dyscrasia oral abstract session Friday, June 3.

For this analysis, 605 patients with newly diagnosed multiple myeloma and treated with continuous lenalidomide (brand name Revlimid) following autologous stem cell transplant were compared to 604 patients who were treated with placebo or no maintenance.

The investigational treatment was combined with chemotherapy and an autologous stem cell transplant — a new strategy designed to target and kill the cells that give rise to myeloma cells.

«Autologous stem cell transplant should be standard care for HIV - associated lymphoma: Multicenter, Phase II trial suggests autologous transplant should be standard of care for HIV patients with relapsed / treatment - resistant lymphoma.»

Based on our data, autologous stem cell transplant should be considered the standard of care for patients with HIV - related lymphomas for the same indications and under the same circumstances that we would use it in patients without HIV infection.»

After chemotherapy and an autologous stem cell transplant failed to stop her cancer, she qualified for the final spot in Sattva Neelapu's study of CAR T - cell therapy for lymphoma.

The US Food and Drug Administration (FDA) has granted Priority Review designation for tisagenlecleucel (Kymriah), formerly known as CTL019, for treatment of adult patients with relapsed or refractory diffuse large B - cell lymphoma (DLBCL) who are ineligible for, or have relapsed after, autologous stem cell transplant.

Diagnosed with multiple myeloma or lymphoma and prescribed an autologous stem cell transplant (patient receiving their own stem cells)

Your donor receives the same G - CSF injections that a person receiving an autologous stem cell transplant receives.

I was diagnosed with non-Hodgkin's diffuse B - cell lymphoma on Aug. 14, 2015, and since then, I have undergone three rounds of chemotherapy, 22 radiation treatments and an autologous stem cell transplant.

That happened right before my autologous stem cell transplant, after I'd done one more round of chemotherapy before my stem cells were harvested.

The really important questions are whether this therapy can be given safely; early in the disease course; and as second - line treatment, replacing an autologous stem cell transplant.

One clinical trial has begun and others will follow that are large phase III, randomized clinical trials comparing salvage chemotherapy plus autologous stem cell transplant versus CAR T - cell therapy, that is, second - line therapy administered earlier in the disease course.

The patients enrolled in the trial had not responded to their last line of therapy or had progressed within 12 months of an autologous stem cell transplant.

Some of the integrative and functional medicine treatments for Hashimoto's thyroiditis include a gluten - free diet, iodine testing and supplementation, dietary changes, low dose naltrexone (LDN), and autologous stem cell transplants.

Two promising new area for Hashimoto's treatment: the use of the drug low dose naltrexone (LDN) and autologous stem cell transplants.